ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 72 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,226 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 793,170 | $7,686,000 | 0.94% |
| Sio Capital Management, LLC | 189,062 | $1,832,000 | 0.36% |
| J. Goldman & Co LP | 168,749 | $1,635,000 | 0.11% |
| Rubric Capital Management LP | 57,518 | $557,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 13,823 | $134,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 66,899 | $648,000 | 0.02% |
| PDT Partners, LLC | 11,539 | $112,000 | 0.01% |
| Global Financial Private Client, LLC | 266 | $2,484 | 0.00% |
| Hartford Financial Management Inc. | 598 | $6,000 | 0.00% |
| FIRST TRUST ADVISORS LP | 34,353 | $333,000 | 0.00% |